Patents by Inventor Frederick Montgomery

Frederick Montgomery has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11940384
    Abstract: Devices and methods for determining the cumulative distribution of a polymer property in a reactor without physical separation of reaction subcomponents. The device includes a means of measuring an instantaneous property of the polymers being produced in a reaction vessel a plurality of times during a polymerization reaction as well as a means of determining the corresponding change in polymer concentration in the reaction vessel between measurements of the instantaneous polymer property. The device also includes a means of computing a statistical distribution appropriate to the polymer characteristic and applying the statistical distribution to a recently measured instantaneous value of the polymer property so as to have an instantaneous distribution of the polymer property and a means of adding together the instantaneous distributions of the polymer property in order to obtain the cumulative distribution of the polymer property in the reactor.
    Type: Grant
    Filed: September 23, 2022
    Date of Patent: March 26, 2024
    Assignees: Yokogawa Fluence Analytics, Inc., THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
    Inventors: Wayne Frederick Reed, Rick D. Montgomery, Michael Felix Drenski, Aide Wu
  • Patent number: 10537697
    Abstract: A method and system for generating and delivering nitric oxide directly to a patient. A reaction chamber is provided that is located at or in close proximity to the patient and reactants within the reaction chamber react together to produce a predetermined amount of nitric oxide. The reaction is controlled by metering at least one of the reactants into the reaction chamber to generate a predetermined quantity of nitric oxide as required by the patient. The reactants can include a nitrite salt, such as sodium nitrite, and a reductant such as ascorbic acid, maleic acid or a mixture thereof. By generating and delivering the nitric oxide directly to the patient in close proximity thereto, the formation of NO2 is minimized. One or both of the reactants may be in liquid form.
    Type: Grant
    Filed: January 27, 2016
    Date of Patent: January 21, 2020
    Assignee: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
    Inventors: Frederick Montgomery, Duncan Bathe
  • Publication number: 20160136376
    Abstract: A method and system for generating and delivering nitric oxide directly to a patient. A reaction chamber is provided that is located at or in close proximity to the patient and reactants within the reaction chamber react together to produce a predetermined amount of nitric oxide. The reaction is controlled by metering at least one of the reactants into the reaction chamber to generate a predetermined quantity of nitric oxide as required by the patient. The reactants can include a nitrite salt, such as sodium nitrite, and a reductant such as ascorbic acid, maleic acid or a mixture thereof. By generating and delivering the nitric oxide directly to the patient in close proximity thereto, the formation of NO2 is minimized. One or both of the reactants may be in liquid form.
    Type: Application
    Filed: January 27, 2016
    Publication date: May 19, 2016
    Applicant: INO Therapeutics LLC
    Inventors: Frederick Montgomery, Duncan Bathe
  • Publication number: 20070190184
    Abstract: A method and system for generating and delivering nitric oxide directly to a patient. A reaction chamber is provided that is located at or in close proximity to the patient and reactants within the reaction chamber react together to produce a predetermined amount of nitric oxide. The reaction is controlled by metering at least one of the reactants into the reaction chamber to generate a predetermined quantity of nitric oxide as required by the patient. The reactants can include a nitrite salt, such as sodium nitrite, and a reductant such as ascorbic acid, maleic acid or a mixture thereof. By generating and delivering the nitric oxide directly to the patient in close proximity thereto, the formation of NO2 is minimized. One or both of the reactants may be in liquid form.
    Type: Application
    Filed: February 16, 2006
    Publication date: August 16, 2007
    Inventors: Frederick Montgomery, Duncan Bathe
  • Publication number: 20070062527
    Abstract: A method and system for delivering a pharmaceutical gas to a patient. The method and system provide a known desired quantity of the pharmaceutical gas to the patient independent of the respiratory pattern of the patient. The preferred pharmaceutical gases are CO and NO, both of which are provided as a concentration in a carrier gas. The gas control system determines the delivery of the pharmaceutical gas to the patient to result in the known desired quantity (e.g. in molecules, milligrams or other quantified units) of the pharmaceutical gas being delivered. Upon completion of that known desired quantity of pharmaceutical gas over a plurality of breaths, the system can either terminate any further delivery of the pharmaceutical gas or can activate an alarm to alert the user that the known quantity has been delivered. The system also has alarm functions to alert the user of possible malfunctions of the system.
    Type: Application
    Filed: September 21, 2005
    Publication date: March 22, 2007
    Inventors: Frederick Montgomery, Duncan Bathe
  • Publication number: 20060073070
    Abstract: A NOx sensing device includes at least one pair of spaced electrodes, at least one of which is made of a conductive oxide, and an oxygen-ion conducting material in bridging electrical communication with the electrodes.
    Type: Application
    Filed: September 24, 2004
    Publication date: April 6, 2006
    Inventors: Frederick Montgomery, David West, Timothy Armstrong, Lonnie Maxey
  • Publication number: 20050092408
    Abstract: Sintered, translucent ceramic microbeads, preferably alumina, titania, zirconia, yttria, zirconium phosphate, or yttrium aluminum garnet (YAG) are doped with one or more optically active species. The beads may be added to substances such as explosives in order to create a distinctive optical signature that identifies a manufacturer, lot number, etc. in the event of the need for forensic analysis. Because the beads have a generally spherical surface, the radius of curvature provides an additional distinguishing characteristic by which a particular sample may be identified. The beads could also be formulated into paints if needed to create distinctive optical signatures for camouflage, decoys, or other countermeasures and could also be applied as a dust to track the movement of personnel, vehicles, etc.
    Type: Application
    Filed: May 16, 2003
    Publication date: May 5, 2005
    Inventors: Robert Lauf, Kimberly Anderson, Frederick Montgomery